 | • レポートコード：B-GIR08C2077 • 出版社/出版日：GlobalInfoResearch / 2019年8月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール • 産業分類：Pharma & Healthcare |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、エンコラフェニブの世界市場について調べ、まとめました。種類別セグメントは、50mgカプセル、75mgカプセル等、用途別セグメントは、石油及びガス会社、エネルギー及び公益事業、その他等に区分しました。エンコラフェニブの世界市場概観、企業動向、企業別エンコラフェニブシェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・エンコラフェニブの市場概観 ・エンコラフェニブの企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・エンコラフェニブの企業別販売動向、市場シェア、市場集中度、競争動向 ・エンコラフェニブの世界市場規模 ・エンコラフェニブの北米市場分析（アメリカ、カナダ、メキシコ等） ・エンコラフェニブのアメリカ市場規模推移 ・エンコラフェニブのカナダ市場規模推移 ・エンコラフェニブのメキシコ市場規模推移 ・エンコラフェニブのヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・エンコラフェニブのドイツ市場規模推移 ・エンコラフェニブのイギリス市場規模推移 ・エンコラフェニブのロシア市場規模推移 ・エンコラフェニブのアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・エンコラフェニブの日本市場規模推移 ・エンコラフェニブの中国市場規模推移 ・エンコラフェニブの韓国市場規模推移 ・エンコラフェニブのインド市場規模推移 ・エンコラフェニブの東南アジア市場規模推移 ・エンコラフェニブの南米市場分析（ブラジル、アルゼンチン等） ・エンコラフェニブの中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・エンコラフェニブの種類別分析/販売量、売上、市場シェア（50mgカプセル、75mgカプセル） ・エンコラフェニブの用途別分析/市場規模（石油及びガス会社、エネルギー及び公益事業、その他） ・エンコラフェニブの市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・エンコラフェニブの販売チャネル・代理店・貿易業者・ディーラー分析 |
Scope of the Report:
The worldwide market for Encorafenib is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Encorafenib in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Array BioPharma
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
50mg Capsules
75mg Capsules
Market Segment by Applications, can be divided into
Hospital
Clinic
Pharmacy
Other
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Encorafenib product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Encorafenib, with price, sales, revenue and global market share of Encorafenib in 2017 and 2018.
Chapter 3, the Encorafenib competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Encorafenib breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Encorafenib market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Encorafenib sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Encorafenib Introduction
1.2 Market Analysis by Type
1.2.1 50mg Capsules
1.2.2 75mg Capsules
1.3 Market Analysis by Applications
1.3.1 Hospital
1.3.2 Clinic
1.3.3 Pharmacy
1.3.4 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Array BioPharma
2.1.1 Business Overview
2.1.2 Encorafenib Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Array BioPharma Encorafenib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Encorafenib Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Encorafenib Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Encorafenib Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Encorafenib Manufacturer Market Share in 2018
3.3.2 Top 6 Encorafenib Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Encorafenib Market Analysis by Regions
4.1 Global Encorafenib Sales, Revenue and Market Share by Regions
4.1.1 Global Encorafenib Sales and Market Share by Regions (2014-2019)
4.1.2 Global Encorafenib Revenue and Market Share by Regions (2014-2019)
4.2 North America Encorafenib Sales and Growth Rate (2014-2019)
4.3 Europe Encorafenib Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Encorafenib Sales and Growth Rate (2014-2019)
4.5 South America Encorafenib Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Encorafenib Sales and Growth Rate (2014-2019)
5 North America Encorafenib by Country
5.1 North America Encorafenib Sales, Revenue and Market Share by Country
5.1.1 North America Encorafenib Sales and Market Share by Country (2014-2019)
5.1.2 North America Encorafenib Revenue and Market Share by Country (2014-2019)
5.2 United States Encorafenib Sales and Growth Rate (2014-2019)
5.3 Canada Encorafenib Sales and Growth Rate (2014-2019)
5.4 Mexico Encorafenib Sales and Growth Rate (2014-2019)
6 Europe Encorafenib by Country
6.1 Europe Encorafenib Sales, Revenue and Market Share by Country
6.1.1 Europe Encorafenib Sales and Market Share by Country (2014-2019)
6.1.2 Europe Encorafenib Revenue and Market Share by Country (2014-2019)
6.2 Germany Encorafenib Sales and Growth Rate (2014-2019)
6.3 UK Encorafenib Sales and Growth Rate (2014-2019)
6.4 France Encorafenib Sales and Growth Rate (2014-2019)
6.5 Russia Encorafenib Sales and Growth Rate (2014-2019)
6.6 Italy Encorafenib Sales and Growth Rate (2014-2019)
7 Asia-Pacific Encorafenib by Country
7.1 Asia-Pacific Encorafenib Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Encorafenib Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Encorafenib Revenue and Market Share by Country (2014-2019)
7.2 China Encorafenib Sales and Growth Rate (2014-2019)
7.3 Japan Encorafenib Sales and Growth Rate (2014-2019)
7.4 Korea Encorafenib Sales and Growth Rate (2014-2019)
7.5 India Encorafenib Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Encorafenib Sales and Growth Rate (2014-2019)
8 South America Encorafenib by Country
8.1 South America Encorafenib Sales, Revenue and Market Share by Country
8.1.1 South America Encorafenib Sales and Market Share by Country (2014-2019)
8.1.2 South America Encorafenib Revenue and Market Share by Country (2014-2019)
8.2 Brazil Encorafenib Sales and Growth Rate (2014-2019)
8.3 Argentina Encorafenib Sales and Growth Rate (2014-2019)
8.4 Colombia Encorafenib Sales and Growth Rate (2014-2019)
9 Middle East and Africa Encorafenib by Countries
9.1 Middle East and Africa Encorafenib Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Encorafenib Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Encorafenib Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Encorafenib Sales and Growth Rate (2014-2019)
9.3 Turkey Encorafenib Sales and Growth Rate (2014-2019)
9.4 Egypt Encorafenib Sales and Growth Rate (2014-2019)
9.5 Nigeria Encorafenib Sales and Growth Rate (2014-2019)
9.6 South Africa Encorafenib Sales and Growth Rate (2014-2019)
10 Global Encorafenib Market Segment by Type
10.1 Global Encorafenib Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Encorafenib Sales and Market Share by Type (2014-2019)
10.1.2 Global Encorafenib Revenue and Market Share by Type (2014-2019)
10.2 50mg Capsules Sales Growth and Price
10.2.1 Global 50mg Capsules Sales Growth (2014-2019)
10.2.2 Global 50mg Capsules Price (2014-2019)
10.3 75mg Capsules Sales Growth and Price
10.3.1 Global 75mg Capsules Sales Growth (2014-2019)
10.3.2 Global 75mg Capsules Price (2014-2019)
11 Global Encorafenib Market Segment by Application
11.1 Global Encorafenib Sales Market Share by Application (2014-2019)
11.2 Hospital Sales Growth (2014-2019)
11.3 Clinic Sales Growth (2014-2019)
11.4 Pharmacy Sales Growth (2014-2019)
11.5 Other Sales Growth (2014-2019)
12 Encorafenib Market Forecast (2019-2024)
12.1 Global Encorafenib Sales, Revenue and Growth Rate (2019-2024)
12.2 Encorafenib Market Forecast by Regions (2019-2024)
12.2.1 North America Encorafenib Market Forecast (2019-2024)
12.2.2 Europe Encorafenib Market Forecast (2019-2024)
12.2.3 Asia-Pacific Encorafenib Market Forecast (2019-2024)
12.2.4 South America Encorafenib Market Forecast (2019-2024)
12.2.5 Middle East and Africa Encorafenib Market Forecast (2019-2024)
12.3 Encorafenib Market Forecast by Type (2019-2024)
12.3.1 Global Encorafenib Sales Forecast by Type (2019-2024)
12.3.2 Global Encorafenib Market Share Forecast by Type (2019-2024)
12.4 Encorafenib Market Forecast by Application (2019-2024)
12.4.1 Global Encorafenib Sales Forecast by Application (2019-2024)
12.4.2 Global Encorafenib Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
Figure Encorafenib Picture
Table Product Specifications of Encorafenib
Figure Global Sales Market Share of Encorafenib by Types in 2018
Table Encorafenib Types for Major Manufacturers
Figure 50mg Capsules Picture
Figure 75mg Capsules Picture
Figure Encorafenib Sales Market Share by Applications in 2018
Figure Hospital Picture
Figure Clinic Picture
Figure Pharmacy Picture
Figure Other Picture
Figure United States Encorafenib Revenue (Value) and Growth Rate (2014-2024)
Figure Canada Encorafenib Revenue (Value) and Growth Rate (2014-2024)
Figure Mexico Encorafenib Revenue (Value) and Growth Rate (2014-2024)
Figure Germany Encorafenib Revenue (Value) and Growth Rate (2014-2024)
Figure France Encorafenib Revenue (Value) and Growth Rate (2014-2024)
Figure UK Encorafenib Revenue (Value) and Growth Rate (2014-2024)
Figure Russia Encorafenib Revenue (Value) and Growth Rate (2014-2024)
Figure Italy Encorafenib Revenue (Value) and Growth Rate (2014-2024)
Figure China Encorafenib Revenue (Value) and Growth Rate (2014-2024)
Figure Japan Encorafenib Revenue (Value) and Growth Rate (2014-2024)
Figure Korea Encorafenib Revenue (Value) and Growth Rate (2014-2024)
Figure India Encorafenib Revenue (Value) and Growth Rate (2014-2024)
Figure Southeast Asia Encorafenib Revenue (Value) and Growth Rate (2014-2024)
Figure Brazil Encorafenib Revenue (Value) and Growth Rate (2014-2024)
Figure Egypt Encorafenib Revenue (Value) and Growth Rate (2014-2024)
Figure Saudi Arabia Encorafenib Revenue (Value) and Growth Rate (2014-2024)
Figure South Africa Encorafenib Revenue (Value) and Growth Rate (2014-2024)
Figure Nigeria Encorafenib Revenue (Value) and Growth Rate (2014-2024)
Table Array BioPharma Basic Information, Manufacturing Base and Competitors
Table Array BioPharma Encorafenib Type and Applications
Table Array BioPharma Encorafenib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Global Encorafenib Sales by Manufacturer (2017-2018)
Figure Global Encorafenib Sales Market Share by Manufacturer in 2017
Figure Global Encorafenib Sales Market Share by Manufacturer in 2018
Table Global Encorafenib Revenue by Manufacturer (2017-2018)
Figure Global Encorafenib Revenue Market Share by Manufacturer in 2017
Figure Global Encorafenib Revenue Market Share by Manufacturer in 2018
Figure Top 3 Encorafenib Manufacturer (Revenue) Market Share in 2018
Figure Top 6 Encorafenib Manufacturer (Revenue) Market Share in 2018
Figure Global Encorafenib Sales and Growth Rate (2014-2019)
Figure Global Encorafenib Revenue and Growth Rate (2014-2019)
Table Global Encorafenib Sales by Regions (2014-2019)
Table Global Encorafenib Sales Market Share by Regions (2014-2019)
Table Global Encorafenib Revenue by Regions (2014-2019)
Figure Global Encorafenib Revenue Market Share by Regions (2014-2019)
Figure Global Encorafenib Revenue Market Share by Regions in 2018
Figure North America Encorafenib Sales and Growth Rate (2014-2019)
Figure Europe Encorafenib Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Encorafenib Sales and Growth Rate (2014-2019)
Figure South America Encorafenib Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Encorafenib Sales and Growth Rate (2014-2019)
Figure North America Encorafenib Revenue and Growth Rate (2014-2019)
Table North America Encorafenib Sales by Countries (2014-2019)
Table North America Encorafenib Sales Market Share by Countries (2014-2019)
Figure North America Encorafenib Sales Market Share by Countries (2014-2019)
Figure North America Encorafenib Sales Market Share by Countries in 2018
Table North America Encorafenib Revenue by Countries (2014-2019)
Table North America Encorafenib Revenue Market Share by Countries (2014-2019)
Figure North America Encorafenib Revenue Market Share by Countries (2014-2019)
Figure North America Encorafenib Revenue Market Share by Countries in 2018
Figure United States Encorafenib Sales and Growth Rate (2014-2019)
Figure Canada Encorafenib Sales and Growth Rate (2014-2019)
Figure Mexico Encorafenib Sales and Growth Rate (2014-2019)
Figure Europe Encorafenib Revenue and Growth Rate (2014-2019)
Table Europe Encorafenib Sales by Countries (2014-2019)
Table Europe Encorafenib Sales Market Share by Countries (2014-2019)
Table Europe Encorafenib Revenue by Countries (2014-2019)
Figure Europe Encorafenib Revenue Market Share by Countries (2014-2019)
Figure Europe Encorafenib Revenue Market Share by Countries in 2018
Figure Germany Encorafenib Sales and Growth Rate (2014-2019)
Figure UK Encorafenib Sales and Growth Rate (2014-2019)
Figure France Encorafenib Sales and Growth Rate (2014-2019)
Figure Russia Encorafenib Sales and Growth Rate (2014-2019)
Figure Italy Encorafenib Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Encorafenib Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Encorafenib Sales by Countries (2014-2019)
Table Asia-Pacific Encorafenib Sales Market Share by Countries (2014-2019)
Figure Asia-Pacific Encorafenib Sales Market Share by Countries 2018
Table Asia-Pacific Encorafenib Revenue by Countries (2014-2019)
Figure Asia-Pacific Encorafenib Revenue Market Share by Countries 2018
Figure China Encorafenib Sales and Growth Rate (2014-2019)
Figure Japan Encorafenib Sales and Growth Rate (2014-2019)
Figure Korea Encorafenib Sales and Growth Rate (2014-2019)
Figure India Encorafenib Sales and Growth Rate (2014-2019)
Figure Southeast Asia Encorafenib Sales and Growth Rate (2014-2019)
Figure South America Encorafenib Revenue and Growth Rate (2014-2019)
Table South America Encorafenib Sales by Countries (2014-2019)
Table South America Encorafenib Sales Market Share by Countries (2014-2019)
Figure South America Encorafenib Sales Market Share by Countries in 2018
Table South America Encorafenib Revenue by Countries (2014-2019)
Table South America Encorafenib Revenue Market Share by Countries (2014-2019)
Figure South America Encorafenib Revenue Market Share by Countries in 2018
Figure Brazil Encorafenib Sales and Growth Rate (2014-2019)
Figure Argentina Encorafenib Sales and Growth Rate (2014-2019)
Figure Colombia Encorafenib Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Encorafenib Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Encorafenib Sales by Countries (2014-2019)
Table Middle East and Africa Encorafenib Sales Market Share by Countries (2014-2019)
Figure Middle East and Africa Encorafenib Sales Market Share by Countries in 2018
Table Middle East and Africa Encorafenib Revenue by Countries (2014-2019)
Table Middle East and Africa Encorafenib Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Encorafenib Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Encorafenib Revenue Market Share by Countries in 2018
Figure Saudi Arabia Encorafenib Sales and Growth Rate (2014-2019)
Figure UAE Encorafenib Sales and Growth Rate (2014-2019)
Figure Egypt Encorafenib Sales and Growth Rate (2014-2019)
Figure Nigeria Encorafenib Sales and Growth Rate (2014-2019)
Figure South Africa Encorafenib Sales and Growth Rate (2014-2019)
Table Global Encorafenib Sales by Type (2014-2019)
Table Global Encorafenib Sales Share by Type (2014-2019)
Table Global Encorafenib Revenue by Type (2014-2019)
Table Global Encorafenib Revenue Share by Type (2014-2019)
Figure Global 50mg Capsules Sales Growth (2014-2019)
Figure Global 50mg Capsules Price (2014-2019)
Figure Global 75mg Capsules Sales Growth (2014-2019)
Figure Global 75mg Capsules Price (2014-2019)
Table Global Encorafenib Sales by Application (2014-2019)
Table Global Encorafenib Sales Share by Application (2014-2019)
Figure Global Clinic Sales Growth (2014-2019)
Figure Global Pharmacy Sales Growth (2014-2019)
Figure Global Other Sales Growth (2014-2019)
Figure Global Encorafenib Sales, Revenue and Growth Rate (2019-2024)
Table Global Encorafenib Sales Forecast by Regions (2019-2024)
Table Global Encorafenib Market Share Forecast by Regions (2019-2024)
Figure North America Sales Encorafenib Market Forecast (2019-2024)
Figure Europe Sales Encorafenib Market Forecast (2019-2024)
Figure Asia-Pacific Sales Encorafenib Market Forecast (2019-2024)
Figure South America Sales Encorafenib Market Forecast (2019-2024)
Figure Middle East and Africa Sales Encorafenib Market Forecast (2019-2024)
Table Global Encorafenib Sales Forecast by Type (2019-2024)
Table Global Encorafenib Market Share Forecast by Type (2019-2024)
Table Global Encorafenib Sales Forecast by Application (2019-2024)
Table Global Encorafenib Market Share Forecast by Application (2019-2024)
Table Distributors/Traders/ Dealers List
セリチニブの世界市場予測 2024年：メーカー別、地域別、種類・用途別（～2024） Scope of the Report: The worldwide market for Ceritinib is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Ceritinib in global market, e…- 吸入カプセルの世界市場予測 2024年：メーカー別、地域別、種類・用途別（～2024） Inhalation Capsules are used to deliver medical powders to the human lung with a special device. Designed as functional capsules, Inhalation capsules contain less than 5% residue of medicine on the inner wall of the capsule, thus enhancing the efficacy of the medicine taken. Scope of the Report: The…
- 蒸気カプセルの世界市場予測 2024年：メーカー別、地域別、種類・用途別（～2024） Scope of the Report: The worldwide market for Vapor Capsules is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Vapor Capsules in global…
- HPMCカプセルの世界市場予測 2024年：メーカー別、地域別、種類・用途別（～2024） HPMC Capsules are two-piece capsules made from cellulosic raw materials that satisfy vegetarian, religion, cultural and policy needs. These vegetable capsules are an attractive, all natural dosage form that retain all the advantages - easy to swallow, effectively mask taste and odor, and allow produ…
- ベジタリアン系カプセルの世界市場予測 2024年：メーカー別、地域別、種類・用途別（～2024） Scope of the Report: The worldwide market for Vegetarian Based Capsules is expected to grow at a CAGR of roughly over the next five years, will reach million US$ in 2024, from million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Vegetarian Based Capsul…